MedPath

The efficacy of gait training using a body weight support treadmill and visual biofeedback in patients with subacute stroke: a randomized controlled trial

Completed
Conditions
hemiparesis
gait limitations
gait assymetry
body balance
stroke
Stroke - Ischaemic
Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation
Registration Number
ACTRN12616001283460
Lead Sponsor
Mariusz Druzbicki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

First-time ischemic stroke in subacute phase (less than 60 days from stroke)
Unilateral hemiplegia
Independent gait
Brunnstrom Motor Recovery Stage (leg) from 2 to 3 stages

Exclusion Criteria

Second or another stroke incydent
severe heart insufficiency and uncontrolled arterial hypertension
cognitive disorders impairing the understanding of and ability to follow instructions
visual field disturbances caused by a stroke or other visual disturbances impairing normal vision
orthopedic disorders significantly affecting the gait of participants
Untreated deep vein thrombosis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Temporal and spatial parameters of gait assessed by 3D motion analysis system (BTS Smart, BTS Bioengineering, Milan, Italy)<br><br>[Baseline, after 3 weeks of treatment];Kinematic parameters of gait assessed by 3D motion analysis system (BTS Smart, BTS Bioengineering, Milan, Italy)[Baseline, after 3 weeks of treatment];Changes in gait symmetry ratio. The symmetry ratio will be calculated on the basis of analysis of the kinematic, temporal and spatial gait parameters for the right and left lower limb. A symmetry ratio will be calculated for all analyzed parameters. The left and right average values of swing time and stance time, step length, total hip and knee range of motion and intra-limb ratio of swing: stance time (SW/ST) a ratio with the largest value in the numerator so that all values for every individual were >1.0. A ratio value of 1.0 denotes perfect symmetry.[Baseline and after 3 weeks of treatment]
Secondary Outcome Measures
NameTimeMethod
Change in gait speed assessed in the 10 meter test.[Baseline, after 3 weeks of treatment];Change in muscular activity assessed by superficial EMG (Noraxon TELEMYO DTS,Noraxon U.S.A. Inc.)[Baseline, after 3 weeks of treatment];Change in functional capacity assessed using Barthel index[Baseline, after 3 weeks of treatment];Balance, assessed with postural sway on portable force plate (AMTI BP/OR). Analysed will be the length of the path of movement of COP (mm), the surface area of movement of COP (mm2), COP range scalar in anteroposterior (A-P) direction and COP range scalar in mediolateral (M-L) (mm) direction. [Baseline, after 3 weeks of treatment];Dynamic balance will be assessed by the Timed Up and Go Test[Baseline, after 3 weeks of treatment]
© Copyright 2025. All Rights Reserved by MedPath